多西紫杉醇
前列腺癌
癌症研究
细胞凋亡
生物
细胞培养
癌症
药理学
内科学
化学
医学
肿瘤科
遗传学
作者
Amanda O’Neill,Maria Prencipe,Catherine Dowling,Yue Fan,Laoighse Mulrane,William M. Gallagher,Darran P. O’Connor,Robert O’Connor,Aoife Devery,Claire Corcoran,Sweta Rani,Lorraine O’Driscoll,John M. Fitzpatrick,R. William G. Watson
出处
期刊:Molecular Cancer
[Springer Nature]
日期:2011-01-01
卷期号:10 (1): 126-126
被引量:170
标识
DOI:10.1186/1476-4598-10-126
摘要
There is no effective treatment strategy for advanced castration-resistant prostate cancer. Although Docetaxel (Taxotere®) represents the most active chemotherapeutic agent it only gives a modest survival advantage with most patients eventually progressing because of inherent or acquired drug resistance. The aims of this study were to further investigate the mechanisms of resistance to Docetaxel. Three Docetaxel resistant sub-lines were generated and confirmed to be resistant to the apoptotic and anti-proliferative effects of increasing concentrations of Docetaxel.The resistant DU-145 R and 22RV1 R had expression of P-glycoprotein and its inhibition with Elacridar partially and totally reversed the resistant phenotype in the two cell lines respectively, which was not seen in the PC-3 resistant sublines. Resistance was also not mediated in the PC-3 cells by cellular senescence or autophagy but multiple changes in pro- and anti-apoptotic genes and proteins were demonstrated. Even though there were lower basal levels of NF-κB activity in the PC-3 D12 cells compared to the Parental PC-3, docetaxel induced higher NF-κB activity and IκB phosphorylation at 3 and 6 hours with only minor changes in the DU-145 cells. Inhibition of NF-κB with the BAY 11-7082 inhibitor reversed the resistance to Docetaxel.This study confirms that multiple mechanisms contribute to Docetaxel resistance and the central transcription factor NF-κB plays an immensely important role in determining docetaxel-resistance which may represent an appropriate therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI